San Francisco Sentry Investment Group’s Abiomed Inc ABMD Stock Holding History

San Francisco Sentry Investment Group’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5	Closed	-$1K	–	908
2020 Q1	$1K	Sell	5 -117	-96%	-$19.4K	﹤0.01%	855
2019 Q4	$21K	Buy	122 +117	+2,340%	+$21.7K	0.01%	485
2019 Q3	$1K	Buy	+5	New	+$1.08K	﹤0.01%	887
2019 Q2	–	Sell	-13	Closed	-$4K	–	1012
2019 Q1	$4K	Buy	13 +2	+18%	+$665	﹤0.01%	687
2018 Q4	$4K	Buy	11 +8	+267%	+$2.78K	﹤0.01%	680
2018 Q3	$1K	Buy	+3	New	+$1.18K	﹤0.01%	883
2013 Q4	–	Sell	-2,000	Closed	-$38K	–	667
2013 Q3	$38K	Hold	2,000	–	–	0.01%	345
2013 Q2	$43K	Buy	+2,000	New	+$40.2K	0.02%	326

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

San Francisco Sentry Investment Group's ABMD Position: Q2 2020 in Review

San Francisco Sentry Investment Group sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 5 shares — an estimated $1K sold.

San Francisco Sentry Investment Group first reported a position in ABMD in Q2 2013 and held it in 8 quarters. The position peaked at $43K in Q2 2013. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

San Francisco Sentry Investment Group reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
San Francisco Sentry Investment Group sold 5 Abiomed Inc shares in Q2 2020, an estimated $1K.
San Francisco Sentry Investment Group first reported a position in Abiomed Inc in Q2 2013 and held it in 8 quarters.
San Francisco Sentry Investment Group's Abiomed Inc position peaked at $43K in Q2 2013.
460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2020, filed 17 Jul 2020.